問卷

TPIDB > Principal Investigator

Principal Investigator


MacKay Memorial Hospital

Division of Endocrinology

更新時間:2025-10-18

林君璐
  • Co-Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

2Cases

2026-05-11 - 2030-01-07

Phase III

Not yet recruiting
Efficacy and safety of NNC0487-0111 compared to placebo on morbidity and mortality in people with heart failure with preserved or mildly reduced ejection fraction and obesity (HF-POLARIS).
  • Condition/Disease

    Heart Failure, Obesity

  • Test Drug

    NNC0487-0111 B

Participate Sites
5Sites

Not yet recruiting5Sites

2025-03-01 - 2030-06-30

Active
A phase III, randomized, double-blind, placebo-controlled, event-driven trial was conducted to evaluate the effect of Baxdrostat in combination with Dapagliflozin compared to Dapagliflozin alone on the risk of first-time heart failure and cardiovascular death in participants at high risk of developing heart failure.
  • Condition/Disease

    The time elapsed before the first occurrence of any of the following events: • Hospitalization due to HF • Non-hospitalized HF • Death due to CV

  • Test Drug

    Baxdrostat Dapagliflozin

Participate Sites
18Sites

Recruiting18Sites